Table 1.
Pre-treatment Characteristics, COX-2 measured by AQUA®
| Missing COX-2 (n=41) | Determined COX-2 (n=37) | COX-2 < Median (n=18) | COX-2 ≥ Median (n=19) | |
|---|---|---|---|---|
| Age | ||||
| Median | 44 | 47 | 42 | 47 |
| Range | 24 – 68 | 30 – 66 | 30 – 66 | 32 – 59 |
| n | % | n | % | n | % | n | % | |
|---|---|---|---|---|---|---|---|---|
| Zubrod | ||||||||
| 0 | 36 | 88 | 21 | 57 | 9 | 50 | 12 | 63 |
| 1 | 4 | 10 | 15 | 41 | 9 | 50 | 6 | 32 |
| 2 | 1 | 2 | 1 | 3 | 0 | 0 | 1 | 5 |
| FIGO Stage | ||||||||
| IB | 7 | 17 | 11 | 30 | 6 | 33 | 5 | 26 |
| IIA | 1 | 2 | 3 | 8 | 3 | 17 | 0 | 0 |
| IIB | 22 | 54 | 18 | 49 | 7 | 39 | 11 | 58 |
| IIIB | 9 | 22 | 4 | 11 | 2 | 11 | 2 | 11 |
| IVA | 2 | 5 | 1 | 3 | 0 | 0 | 1 | 5 |
| Pelvic Lymph Nodes | ||||||||
| Not Evaluable | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Negative | 32 | 78 | 32 | 86 | 14 | 78 | 18 | 95 |
| Positive | 7 | 17 | 3 | 8 | 2 | 11 | 1 | 5 |
| Equivocal | 0 | 0 | 2 | 5 | 2 | 11 | 0 | 0 |
| Histology | ||||||||
| Squamous cell Ccarcinoma | 36 | 88 | 32 | 86 | 17 | 94 | 15 | 79 |
| Adenocarcinoma | 3 | 7 | 5 | 14 | 1 | 6 | 4 | 21 |
| Adenosquamous | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hydronephrosis | ||||||||
| None | 38 | 93 | 33 | 89 | 17 | 94 | 16 | 84 |
| Unilateral | 3 | 7 | 3 | 8 | 1 | 6 | 2 | 11 |
| Bilateral | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 5 |